Nifty
:
25285.35
Sensex
:
82500.82
103.55 (0.41%)
328.72 (0.40%)
Nifty
Sensex
:
:
25285.35
82500.82
103.55 (0.41%)
328.72 (0.40%)

Deccan Health Care Ltd.

Pharmaceuticals & Drugs

Rating :
33/99

BSE: 542248 | NSE: Not Listed

NSE BSE
16.42
10-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  16.65
  •  17
  •  16.05
  •  16.84
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  58691
  •  975271
  •  17
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 40.64
  • 39.34
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 38.23
  • N/A
  • 0.38

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 18.42%
  • 14.35%
  • 46.52%
  • FII
  • DII
  • Others
  • 0%
  • 5.37%
  • 15.34%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.38
  • 17.31
  • 18.58

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.72
  • 9.08
  • 9.95

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -13.40
  • 24.36
  • 55.25

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 124.08

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 0.61

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 18.49

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
22.14
15.06
47.01%
20.75
15.97
29.93%
20.43
15.34
33.18%
18.82
17.20
9.42%
Expenses
21.39
14.20
50.63%
20.14
15.29
31.72%
19.85
14.12
40.58%
17.72
16.15
9.72%
EBITDA
0.75
0.86
-12.79%
0.60
0.68
-11.76%
0.58
1.22
-52.46%
1.10
1.04
5.77%
EBIDTM
3.39%
5.73%
2.91%
4.25%
2.85%
7.96%
5.84%
6.06%
Other Income
0.01
0.00
0
0.01
0.01
0.00%
0.00
0.00
0
0.00
0.00
0
Interest
0.02
0.02
0.00%
0.02
0.02
0.00%
0.02
0.04
-50.00%
0.03
0.00
0
Depreciation
0.41
0.36
13.89%
0.36
0.36
0.00%
0.37
0.40
-7.50%
0.37
0.32
15.62%
PBT
0.33
0.49
-32.65%
0.23
0.31
-25.81%
0.20
0.79
-74.68%
0.71
0.72
-1.39%
Tax
0.10
0.12
-16.67%
0.11
0.18
-38.89%
0.06
0.26
-76.92%
0.18
0.18
0.00%
PAT
0.24
0.36
-33.33%
0.12
0.13
-7.69%
0.14
0.53
-73.58%
0.53
0.54
-1.85%
PATM
1.07%
2.41%
0.59%
0.81%
0.71%
3.42%
2.81%
3.15%
EPS
0.10
0.18
-44.44%
0.05
0.06
-16.67%
0.06
0.26
-76.92%
0.25
0.32
-21.88%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
82.14
75.06
59.73
45.02
33.17
33.78
Net Sales Growth
29.21%
25.67%
32.67%
35.73%
-1.81%
 
Cost Of Goods Sold
54.25
47.50
37.48
24.96
14.35
18.43
Gross Profit
27.89
27.56
22.25
20.05
18.82
15.35
GP Margin
33.95%
36.72%
37.25%
44.54%
56.74%
45.44%
Total Expenditure
79.10
71.91
55.99
43.06
27.82
31.74
Power & Fuel Cost
-
0.47
0.43
0.42
0.44
0.42
% Of Sales
-
0.63%
0.72%
0.93%
1.33%
1.24%
Employee Cost
-
4.44
3.52
3.32
2.20
2.92
% Of Sales
-
5.92%
5.89%
7.37%
6.63%
8.64%
Manufacturing Exp.
-
4.36
2.59
1.91
1.76
1.12
% Of Sales
-
5.81%
4.34%
4.24%
5.31%
3.32%
General & Admin Exp.
-
2.36
2.22
1.37
0.92
1.13
% Of Sales
-
3.14%
3.72%
3.04%
2.77%
3.35%
Selling & Distn. Exp.
-
12.76
9.17
11.00
7.82
6.77
% Of Sales
-
17.00%
15.35%
24.43%
23.58%
20.04%
Miscellaneous Exp.
-
0.01
0.58
0.06
0.34
0.96
% Of Sales
-
0.01%
0.97%
0.13%
1.03%
2.84%
EBITDA
3.03
3.15
3.74
1.96
5.35
2.04
EBITDA Margin
3.69%
4.20%
6.26%
4.35%
16.13%
6.04%
Other Income
0.02
0.01
0.03
0.02
0.22
0.06
Interest
0.09
0.07
0.09
0.12
0.15
0.11
Depreciation
1.51
1.45
1.47
1.43
1.47
1.47
PBT
1.47
1.63
2.21
0.44
3.94
0.52
Tax
0.45
0.47
0.72
0.13
0.22
0.13
Tax Rate
30.61%
28.83%
32.58%
29.55%
40.74%
25.00%
PAT
1.03
1.16
1.49
0.31
0.32
0.39
PAT before Minority Interest
1.03
1.16
1.49
0.31
0.32
0.39
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
1.25%
1.55%
2.49%
0.69%
0.96%
1.15%
PAT Growth
-33.97%
-22.15%
380.65%
-3.12%
-17.95%
 
EPS
0.42
0.47
0.60
0.13
0.13
0.16

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
106.39
96.91
81.56
76.94
76.62
Share Capital
23.43
20.38
17.04
15.71
15.71
Total Reserves
81.85
75.19
64.52
61.23
60.91
Non-Current Liabilities
2.84
3.64
3.47
3.19
2.93
Secured Loans
0.26
0.56
0.47
0.83
0.45
Unsecured Loans
0.63
1.12
0.92
0.13
0.21
Long Term Provisions
0.25
0.11
0.09
0.14
0.14
Current Liabilities
15.70
7.50
11.75
10.49
12.71
Trade Payables
8.98
4.28
8.43
5.81
5.66
Other Current Liabilities
5.05
2.21
2.42
4.15
5.05
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
1.67
1.00
0.90
0.53
2.00
Total Liabilities
124.93
108.05
96.78
90.62
92.26
Net Block
14.38
15.69
16.85
18.53
19.87
Gross Block
33.74
33.60
33.29
33.49
33.60
Accumulated Depreciation
19.36
17.90
16.44
14.96
13.73
Non Current Assets
18.69
19.86
21.01
22.67
25.81
Capital Work in Progress
0.00
0.00
0.00
0.00
0.07
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1.79
1.78
1.77
1.77
3.50
Other Non Current Assets
2.51
2.39
2.39
2.37
2.37
Current Assets
106.24
88.18
75.77
67.96
66.46
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
42.60
45.70
46.75
46.50
44.98
Sundry Debtors
12.54
9.89
11.99
12.82
12.47
Cash & Bank
3.55
2.60
1.41
2.67
3.22
Other Current Assets
47.54
0.66
0.01
0.01
5.79
Short Term Loans & Adv.
45.98
29.33
15.61
5.95
5.76
Net Current Assets
90.54
80.69
64.02
57.47
53.75
Total Assets
124.93
108.04
96.78
90.63
92.27

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
-6.43
-12.55
-6.76
-0.57
0.22
PBT
1.63
2.21
0.44
3.94
0.52
Adjustment
1.39
1.57
0.86
-1.78
1.57
Changes in Working Capital
-9.43
-16.32
-7.84
-2.48
-1.73
Cash after chg. in Working capital
-6.42
-12.54
-6.55
-0.32
0.36
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.01
-0.01
-0.22
-0.25
-0.14
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-0.14
-0.30
0.27
-0.05
-0.07
Net Fixed Assets
-0.14
-0.31
0.20
0.18
Net Investments
0.00
0.00
0.00
0.00
Others
0.00
0.01
0.07
-0.23
Cash from Financing Activity
7.52
14.04
5.26
0.07
-0.37
Net Cash Inflow / Outflow
0.95
1.19
-1.23
-0.56
-0.22
Opening Cash & Equivalents
2.60
1.41
2.64
3.22
3.45
Closing Cash & Equivalent
3.55
2.60
1.41
2.67
3.22

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
44.94
46.90
47.86
48.97
48.76
ROA
0.99%
1.46%
0.33%
0.35%
0.42%
ROE
1.15%
1.69%
0.39%
0.42%
0.51%
ROCE
1.65%
2.53%
0.69%
0.89%
0.81%
Fixed Asset Turnover
2.23
1.79
1.35
0.99
1.01
Receivable days
54.52
66.84
100.58
139.13
134.71
Inventory Days
214.70
282.48
378.03
503.31
486.07
Payable days
50.95
61.89
104.04
145.80
112.02
Cash Conversion Cycle
218.27
287.43
374.57
496.65
508.76
Total Debt/Equity
0.01
0.02
0.02
0.02
0.01
Interest Cover
22.97
26.68
4.75
4.57
5.81

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Deccan Health Care - Quarterly Results
    14th Aug 2025, 16:10 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.